Day: March 16, 2026
– Bempedoic Acid Receives Strongest Endorsement from AHA/ACC Multisociety Guideline for Patients with Statin Intolerance and in Primary and Secondary Prevention Patients with Severe Hypercholesterolemia –
– Bempedoic Acid Receives Equal Positioning with PCSK9 mAb and Ezetimibe After Statins for High-Risk Primary Prevention and Clinical ASCVD Not at Very High-Risk Patients –
– Guideline Recognition of Early Combination Lipid-Lowering Therapy and Reintroduction of LDL-C Goals Affirms ‘Lower for Longer is Better’ Approach to Cardiovascular Risk Reduction –
ANN ARBOR, Mich., March 16, 2026 (GLOBE NEWSWIRE) — Esperion (NASDAQ: ESPR) welcomed the inclusion of bempedoic acid for LDL-C lowering and cardiovascular risk reduction in the 2026 Americal College of Cardiology (ACC)/American Heart Association (AHA) Multisociety Guideline on the...
Acumen Pharmaceuticals Announces $35.75 Million Private Placement to Advance Potential Best-in-Class Molecules from Amyloid Beta Oligomer-Selective Enhanced Brain Delivery Portfolio
Written by Customer Service on . Posted in Public Companies.
Financing demonstrates conviction in oligomer-selective approach and follows strong preclinical data, including in vitro, in vivo and non-human primate study results, that support development candidates in Acumen’s transferrin-receptor targeting Enhanced Brain Delivery (EBD™) program
Candidates exceeded key preclinical criteria, demonstrating elevated brain exposure in non-human primates up to 40-fold over native antibodies, low risk of anemia, and robust stability profiles to enable subcutaneous administration
Lead clinical candidate IND targeted for mid-2027NEWTON, Mass., March 16, 2026 (GLOBE NEWSWIRE) — Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) (“Acumen” or the “Company”), a clinical-stage biopharmaceutical company developing novel therapeutics that target toxic soluble amyloid b oligomers (AβOs) for the treatment...
Nova Winter Freight Haul Underway
Written by Customer Service on . Posted in Public Companies.
Anchorage Alaska, March 16, 2026 (GLOBE NEWSWIRE) — Nova Minerals Limited (“Nova” or the “Company”) (NASDAQ: NVA) (ASX: NVA) (FRA: QM3) ) is pleased to announce that the mobilization of heavy equipment to the Estelle Project is underway via the Company’s winter snow road, approximately 150km from Willow. (Figure 1). Ideal winter conditions allowed snow road construction to commence in early December, which involved pre-packing snow, water-flooding for ice thickening at major river crossings, and minor brush clearing. This winter has delivered near perfect snow road conditions with exceptionally cold temperatures that are favorable for the construction of ice bridges over 1.5m (5ft) thick. These bridges are capable of supporting freight loads well over 100,000lb (45,000kg) while preserving a hard snowpack base.
To watch a video of...
Bunker Hill on Track for June 2026 US Mine Restart Launches Exploration Program and Provides Project Update
Written by Customer Service on . Posted in Public Companies.
KELLOGG, Idaho and VANCOUVER, British Columbia, March 16, 2026 (GLOBE NEWSWIRE) — Bunker Hill Mining Corp. (“Bunker Hill” or the “Company”) (TSX-V: BNKR | OTCQB: BHLL), is pleased to provide an update on our progress toward the H1 2026 restart of the Bunker Hill Zinc-Silver-Lead Mine located in the prolific Silver Valley, Idaho, USA.
HIGHLIGHTSSafety First: the project has achieved 40 months with no lost time injuries
Project Progress: construction and commissioning is now 85% complete, and on track for the restart of operations and first concentrate production in June 2026
Processing Plant: the mills are turning, with commissioning advancing ahead of plan, complemented by the hiring of new team members
Filter Plant: 100% of all mechanical installation completed, with contractors advancing the installation of piping and electrical...
Summit Royalties to Combine with Star Royalties to Create a Scaled, High-Growth Royalty Platform
Written by Customer Service on . Posted in Mergers And Acquisitions.
TORONTO, March 16, 2026 (GLOBE NEWSWIRE) — Summit Royalties Ltd. (TSXV: SUM, OTCQB: SUMMF) (the “Company” or “Summit”) and Star Royalties Ltd. (TSXV: STRR, OTCQX: STRFF) (“Star”) are pleased to announce that they have entered into an arrangement agreement (the “Agreement”) pursuant to which, among other things, Summit has agreed to acquire all of the issued and outstanding common shares of Star by way of a court approved Plan of Arrangement under the Canada Business Corporations Act (the “Transaction”).
Assuming completion of the Transaction, holders (“Star Shareholders”) of common shares of Star (“Star Shares”) are entitled to receive 0.360 (the “Exchange Ratio”) of a common share of Summit (each a “Summit Share”) in exchange...
KE Holdings Inc. Announces a Final Cash Dividend of US$0.3 Billion in Aggregate
Written by Customer Service on . Posted in Dividend Reports And Estimates.
BEIJING, March 16, 2026 (GLOBE NEWSWIRE) — KE Holdings Inc. (“Beike” or the “Company”) (NYSE: BEKE and HKEX: 2423), a leading integrated online and offline platform for housing transactions and services, today announced that its board of directors (the “Board”) approved a final cash dividend (the “Dividend”) of US$0.092 per ordinary share, or US$0.276 per ADS, to holders of ordinary shares and holders of ADSs of record as of the close of business on April 8, 2026, Beijing/Hong Kong Time and New York Time, respectively, payable in U.S. dollars. The aggregate amount of the Dividend to be paid will be approximately US$0.3 billion, which will be funded by cash surplus on the Company’s balance sheet.
For holders of ordinary shares, in order to qualify for the Dividend, all valid documents for the transfer of shares accompanied by the...
Mawson Infrastructure Group Inc. Provides Update on Strategic Initiatives
Written by Customer Service on . Posted in Public Companies.
Kaliste Saloom to Present at Emerging Growth Conference on April 2, 2026
MIDLAND, Pa., March 16, 2026 (GLOBE NEWSWIRE) — Mawson Infrastructure Group Inc. (“Mawson” or the “Company”) today provided an update on its progress to deliver value to stockholders.
Mawson has achieved a range of objectives over the past year, including regaining Nasdaq compliance, settling multiple lawsuits, which reduced the Company’s current liabilities by $19 million, and initiating a strategic pivot to artificial intelligence and high-performance computing. As these achievements were obtained over the course of fiscal 2025, the Mawson Board of Directors (the “Board”) formed a Strategic Transactions Committee to evaluate a range of alternatives to the Company, including potential M&A transactions, joint ventures and other opportunities. The Strategic...
Townsquare Reports Q4 and Year End Results; Maintains Current Dividend, Reflecting an 11% Yield Today
Written by Customer Service on . Posted in Public Companies.
Digital Represents 55% of 2025 Total Net Revenue and 56% of 2025 Total Segment ProfitReduced Debt by $23 Million Since the February 2025 Refinancing
PURCHASE, N.Y., March 16, 2026 (GLOBE NEWSWIRE) — Townsquare Media, Inc. (NYSE: TSQ) (“Townsquare”, the “Company,” “we,” “us” or “our”) announced today its financial results for the fourth quarter and year ended December 31, 2025.
“I am pleased to share that Townsquare’s fourth quarter and year end results met our previously issued net revenue and Adjusted EBITDA guidance, reflecting our team’s hard work in the current environment. We are proud that the execution of our Digital First Local Media strategy allowed us to deliver excellent results for our clients, while also outperforming competitors and gaining market share,” commented Bill Wilson, Chief Executive Officer of Townsquare...
Greenwich LifeSciences Announces Use of Commercially Manufactured GP2 in FLAMINGO-01
Written by Customer Service on . Posted in Public Companies.
STAFFORD, Texas, March 16, 2026 (GLOBE NEWSWIRE) — Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the “Company”), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences, today provided the following update on the use of commercially manufactured GP2 in FLAMINGO-01.
All US Sites Treating Patients with Commercially Manufactured GP2
The Company previously announced that the first three commercial lots of GP2 active ingredient were manufactured in 2023 in an approved commercial facility, which could be used to prepare approximately 200,000 doses of GP2. In 2024, the first of three commercial lots filling GP2 into vials for commercial sale or for clinical use was manufactured in a commercial facility....
Snowline Gold Announces Inclusion Into the GDXJ
Written by Customer Service on . Posted in Public Companies.
VANCOUVER, British Columbia, March 16, 2026 (GLOBE NEWSWIRE) — SNOWLINE GOLD CORP. (TSX: SGD) (OTCQB: SNWGF) (the “Company” or “Snowline”) is pleased to announce that it has been included in the VanEck Junior Gold Miners ETF (“GDXJ”). The GDXJ is a widely followed exchange traded fund that provides investors with exposure to a global portfolio of junior and mid‑tier gold and silver mining, development and exploration companies. The rebalancing of the GDXJ will be effective as of market close March 20, 2026.
“We are excited about Snowline’s upcoming addition to the GDXJ,” said Scott Berdahl, CEO & Director of Snowline. “Inclusion increases our visibility among passive and benchmark‑driven investors and may further enhance trading liquidity as our shareholder base continues to broaden.”
ABOUT SNOWLINE GOLD CORP.
Snowline Gold...
